| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 9,557 | 9,179 | 8,149 | 8,503 |
| Cost of sales | 3,082 | 3,011 | 2,968 | 3,310 |
| Research and development | 1,900 | 1,744 | 1,486 | 1,450 |
| Selling, general and administrative | 1,720 | 1,691 | 1,687 | 1,625 |
| Other | 329 | 77 | 830 | 71 |
| Total operating expenses | 7,031 | 6,523 | 6,971 | 6,456 |
| Operating income | 2,526 | 2,656 | 1,178 | 2,047 |
| Interest expense, net | 685 | 694 | 723 | 776 |
| Other income, net | 2,080 | -394 | 1,518 | 1,830 |
| Income before income taxes | 3,921 | 1,568 | 1,973 | 3,101 |
| Provision for income taxes | 705 | 136 | 243 | 271 |
| Net income | 3,216 | 1,432 | 1,730 | 2,830 |
| Basic (in shares) | 538,000,000 | 538,000,000 | 538,000,000 | 537,000,000 |
| Basic (in usd per share) | 5.98 | 2.66 | 3.22 | 5.27 |
| Diluted (in shares) | 542,000,000 | 541,000,000 | 541,000,000 | 542,000,000 |
| Diluted (in usd per share) | 5.93 | 2.65 | 3.2 | 5.22 |
AMGEN INC (AMGN)
AMGEN INC (AMGN)